What is the dosage and usage of Hyoscine (butylbromide) for relieving abdominal cramps and spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hyoscine Butylbromide Dosage and Usage for Abdominal Cramps

For abdominal cramping and spasms, hyoscine butylbromide is an effective antispasmodic that should be considered as a first-line treatment option, with intramuscular administration being more effective than oral forms due to poor oral absorption. 1

Mechanism of Action

Hyoscine butylbromide works as an antimuscarinic agent with high affinity for muscarinic receptors (M2 and M3) located on gastrointestinal smooth muscle cells, producing a direct spasmolytic effect. 2, 3 The drug also blocks nicotinic receptors, contributing to its ganglion-blocking and antispasmodic properties. 2, 4

Clinical Indications

  • Irritable Bowel Syndrome (IBS): The British Society of Gastroenterology recognizes antispasmodics like hyoscine butylbromide as effective treatments for global symptoms and abdominal pain in IBS, though common side effects include dry mouth, visual disturbance, and dizziness. 5

  • Severe or Refractory Abdominal Pain: For severe or refractory abdominal pain in IBS, intramuscular hyoscine has demonstrated efficacy. 5

  • General Gastrointestinal Cramping: The American Gastroenterological Association recommends hyoscine butylbromide for abdominal pain associated with gastrointestinal cramping and spasms. 1

Dosing and Administration

Route Selection

Intramuscular administration is preferred over oral forms for gastrointestinal spasms because oral hyoscine butylbromide has extremely poor absorption (bioavailability <1%). 1, 2 Despite low systemic availability, the drug maintains high tissue affinity for muscarinic receptors at the intestinal site of action. 2

Specific Dosing

While the FDA label provided focuses on veterinary dosing (0.3 mg/kg IV for horses) 6, human dosing for abdominal cramping typically follows these principles:

  • Intramuscular preparations can be used for long-term management at home and are more effective than oral forms. 1

  • Oral/rectal formulations have been evaluated in clinical trials and shown benefit despite poor absorption, as the drug exerts local spasmolytic effects in the intestine. 2

Efficacy Profile

The drug demonstrates concentration-dependent inhibition of smooth muscle activity, with particular effectiveness against spasticity induced by muscarinic stimulation. 3 Sensitivity to hyoscine butylbromide increases along the gastrointestinal tract from esophagus to colon, jejunum, and ileum, which correlates inversely with muscarinic receptor expression patterns. 3

Ten placebo-controlled studies have consistently demonstrated benefit of oral or rectal hyoscine butylbromide for abdominal pain caused by cramping. 2

Safety and Tolerability

Hyoscine butylbromide is generally well-tolerated because it barely crosses the blood-brain barrier due to its quaternary ammonium structure. 1, 2

Common Side Effects

  • Dry mouth, visual disturbance, and dizziness are the most frequently reported anticholinergic effects. 5
  • These side effects may limit tolerability in some patients. 5

Important Contraindications and Cautions

According to the Canadian Association of Gastroenterology, hyoscine butylbromide is contraindicated in patients with:

  • Tachycardia, angina, and cardiac failure (requires careful cardiac monitoring if used). 7
  • Prostatic hypertrophy with urinary retention. 7
  • Patients should be counseled about potential acute angle-closure glaucoma symptoms (eye pain, redness, decreased vision, nausea, vomiting, headache) if the drug has been administered. 7

Clinical Context and Positioning

Hyoscine butylbromide is particularly useful for managing pain associated with IBS and functional gastrointestinal disorders. 8 It has broad applications in gastroenterology and advantages when treating patients with comorbid digestive system pathologies, including functional biliary tract disorders. 8

For patients requiring escalation beyond antispasmodics, tricyclic antidepressants (starting at 10 mg amitriptyline once daily, titrated to 30-50 mg) represent effective second-line therapy for global symptoms and abdominal pain in IBS. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.